These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6098935)

  • 1. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.
    Moschen ME; Farisano G; Bonello C; Benussi G; Barbone F; Gasparini V; Trivello R
    Boll Ist Sieroter Milan; 1987; 66(2):97-100. PubMed ID: 2822063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 6. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 8. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.
    Rousseau WE; Noble GR; Tegtmeier GE; Jordan MC; Chin TD
    N Engl J Med; 1973 Dec; 289(25):1357-9. PubMed ID: 4356637
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on new attenuated strains of type I live poliovirus vaccine. II. Investigation on a series of field trials with "Zhong I9" strain].
    Chen TQ; Li CZ; Ni SF; Shi M; Luo GX; Dong DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Dec; 5(6):373-7. PubMed ID: 6327097
    [No Abstract]   [Full Text] [Related]  

  • 11. [Stage of immunity to Poliovirus type 1 and 3 in adult women and in newborn infants: study of comparative efficiency of 2 methods for determination of neutralizing antibodies].
    Barbi M
    Ann Sclavo; 1972; 14(6):694-704. PubMed ID: 4360238
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroimmunity to poliovirus in Poitiers, France.
    Agius G; Ranger S; Baillargeau E; Rouches C; Castets M
    Eur J Clin Microbiol; 1986 Apr; 5(2):171-3. PubMed ID: 3013629
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
    Herremans MM; Reimerink JH; Ras A; Van Der Avoort HG; Kimman TG; Van Loon AM; Conyn-Van Spaendonck MA; Koopmans MP
    Clin Diagn Lab Immunol; 1997 Nov; 4(6):659-64. PubMed ID: 9384285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated poliovirus vaccine in Finland.
    Oker-Blom N; Penttinen K; Weckström P
    Rev Infect Dis; 1984; 6 Suppl 2():S461-2. PubMed ID: 6330842
    [No Abstract]   [Full Text] [Related]  

  • 16. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
    Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
    Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
    Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

  • 20. [Revaccination of school children with a live vaccine against poliomyelitis].
    Koza J; Matyásová I; Skovránek V; Danes L; Losová M
    Cesk Pediatr; 1983 Apr; 38(4):207-11. PubMed ID: 6303606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.